February 2026 saw robust M&A activity across the pharmaceutical and biotechnology sectors, marked by several high-value ...
Iranian biopharma CinnaGen has secured European marketing authorization for Zandoriah (teriparatide), a biosimilar to Forsteo ...
Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...
Sweden's pharmaceutical exports increased by more than 1% to 154 billion Swedish kroner in 2025. These new trade statistics ...
Chinese biotech Innovent Biologics (HKEX: 01801) has secured approval from China’s National Medical Products Administration ...
Chinese biotech Antengene (SEHK: 6996) has secured reimbursement in South Korea for Xpovio (selinexor) in combination with ...
US pharma giant Pfizer has withdrawn its European application for a marketing authorization of Zumrad (sasanlimab) for the ...
Pain management specialist Grünenthal today announced that it has acquired Kyowa Kirin’s 49% stake in ‘Grünenthal Meds’, ...
Denmark’s pharmaceutical industry association Lif has called on politicians to make patient access to new medicines and the ...
Canada-based clinical-stage biotech Zymeworks ) and Royalty Pharma today announced an agreement for $250 million in funding ...
February 2026 delivered significant signals across the rare disease ecosystem, spanning regulatory approvals, legislative ...
Novo Nordisk today announced an investment of 432 million euro ($510 million) in its facility in Monksland, Athlone, Ireland. This tabletting facility will provide significant additional manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results